Editor’s EmulsionPatient Safety Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSAIIF Pill
DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
EDITOR'S EMULSION
Warm Greetings!!!
Welcome to yet another most pleasant Reading of our newsletter.
It is always my privilege to reach you on 1st & 17th of every month, since the last 11 years. Please do not hesitate to share your comments on this edition to enable us to constantly improve. Please feel free to get in touch with us. You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook.
Stay Healthy. Stay Protected.
Pyush Misra
Editor-in-Chief
DOSE OF THE DAY
Mental & intellectual development is directly related to the quality of our food intake.
As Nutrition Week starts today, let us pledge to convert nutrition awareness into a mass move-ment with a focus on developing practices that nurture good health.
Dr. Mansukh Mandaviya
Minister of Health and Family Welfare;
Chemicals and Fertilizers,
Govt. of India
Sponsor
Patient Safety Capsules
Parliamentary panel asks DoP to share details of PMBJP expansion and fund utilisation
New Delhi, August 24, 2022: The Parliamentary Panel which has looked into the Demand for Grants of the Department of Pharmaceuticals (DoP) for the year 2022-23 has sought the Department to share the steps taken to achieve the target of opening 10,000 stores by March, 2024 under the PradhanMantriBhartiyaJanaushadhiPariyojana (PMBJP) and the details of the utilisations of funds allocated for the current fiscal year.
MSMEs urge govt to put in place a single window system for sanctioning loans under PTUAS
Mumbai, August 24, 2022: Pharma Micro, Small and Medium Enterprises (MSMEs) have appealed to the government to put in place a single window system for sanctioning loans up to maximum Rs. 10 crore to them under Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS) for upgrading their facilities.
Drug Laws & Policy Injections
NPPA reiterates its revised retail price notification for Mankind Pharma’s respiratory disease drugNew Delhi, August 24, 2022: The National Pharmaceutical Pricing Authority (NPPA) has reiterated its stand on revising the retail price of the respiratory disease drug formoterolfumarate combination marketed by Mankind Pharma, stating that the authority cannot be prohibited from making any rectification in the notified retail price on account of an error occurred only due to nomenclature issue of the data.
NPPA panel rejects Intas’ application for exemption from provisions of DPCO for clozapine ER capsules New Delhi, August 25, 2022: The expert panel of National Pharmaceutical Pricing Authority (NPPA) has rejected an application by Intas Pharmaceuticals Ltd for exemption from the provisions of Drug Price Control Order (DPCO) 2013, for various strengths of its formulation clozapine extended release (ER) capsules.
KRPDO sees e-pharmacy in New Drugs Bill to topple future of brick & mortar storesBengaluru, August 25, 2022: The Karnataka Pharma Retailers & Distributors Organization (KPRDO) is of the view that the e-pharmacy in draft of New Drugs, Medical Devices and Cosmetic bill, 2022 will topple future of brick & mortar stores. These are primarily on the new business model of e-pharmacies which have taken off well in the absence of regulations.
ODCOA wants Centre to make amendments in New Drugs Bill 2022 as per provisions of Indian ConstitutionChennai, August 29, 2022: Disagreeing with several provisions in the draft New Drugs Bill 2022, the Odisha Drugs Control Officers Association (ODCOA), through a letter to the under-secretary of the union ministry of health and family welfare, says that the revision and amendment of the drug regulation laws should not be biased against the states who are obliged to implement any act.
DoP invites eligible medical devices firms to apply for newly formed Category B of PLI schemeNew Delhi, August 27, 2022: The Department of Pharmaceuticals (DoP) has called for applications from eligible medical devices firms for the newly created Category B of the production linked incentive (PLI) scheme for promoting domestic manufacturing of medical devices.
Revision in terminologies & clarity in definitions required in draft New Drugs Bill-2022: MTaINew Delhi, August 29, 2022: Appreciating the efforts taken by the government to update the existing law in order to stay updated with global best practices and the ever-evolving field of medical technology through the draft New Drugs, Medical Devices and Cosmetics Bill, 2022, the Medical Technology Association of India (MTaI) has opined that some revision in terminologies and clarity in definitions are required in the Draft Bill.
Pharma Injections
Delhi HC issues favourable order to Novartis on its divisional patent application for dry eye disease drugNew Delhi, August 25, 2022: The Delhi High Court has set aside an order by the Patent Office dismissing a patent application of Swiss pharma major Novartis AG, for its composition for the treatment of dry eye disease, and remanded the matter back for considering the divisional application on its own merits.
Clinical data disclosure critical for success of Bharat Biotech’s Covid-19 intranasal vaccine: GlobalDataNew Delhi, August 27, 2022: Data and analytics firm GlobalData has opined that it is important that the clinical trial results of Bharat Biotech's phase III trial of Covid-19 intranasal vaccine BBV154 be made available in the public domain to understand the overall efficacy of the vaccine.
ASI urges NACO to resume supplies of HIV medicines at every centre Mumbai, August 27, 2022: Expressing concern over shortage of antiretroviral drugs across the country causing severe hardship to patients, the AIDS Society of India (ASI) representing physicians and researchers in HIV care and emerging infectious diseases has urged the National AIDS Control Organization (NACO) of the Union ministry of health and family welfare to resume supplies of HIV medicines at every centre, and ensure minimum one-month dispensation to those stable on the therapy.
Make in India & NDHM to spur design & tech in medical devices and pharma: SuhasTamras Bengaluru, August 26, 2022: The Union government’s Make in India programme and National Digital Health Mission (NDHM) are giving the much-needed impetus for technology adoption in medical devices and pharmaceutical industries, said SuhasTamras, vice president and head, healthcare and lifesciences, Tata Elxsi.
Himachal Pradesh CM thanks PM Modi for allocation of bulk drug park Bengaluru, August 31, 2022: Himachal Pradesh Chief Minister Jai Ram Thakur yesterday thanked Prime Minister NarendraModi for allocating Bulk Drug Pharma Park to the state.
Granules receives USFDA approval for Loperamide Hydrochloride and Simethicone Tablets New Delhi, August 30, 2022: Granules India announced today that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA) for Loperamide Hydrochloride and Simethicone Tablets, 2 mg/125 mg (OTC).
Drug Dopes
Antiviral tecovirimat found safe, effective for monkeypox treatment: StudyAugust 29, 2022: The antiviral tecovirimat appears to be safe and effective for the treatment of monkeypox symptoms and skin lesions, according to a small study. The study on 25 patients with monkeypox, published in the journal JAMA, is one of the earliest to assess and report the outcomes of treating patients with the disease with this antiviral. 
Tomato flu in India: Uttar Pradesh issues advisory to parents of children in vulnerable age groupLucknow, August 27, 2022: In response to the outbreak of tomato flu in Uttar Pradesh, the state government has issued an advisory asking parents to keep their children away from other kids with fever and rash symptoms. The contagious disease is caused by a type of viral illness known as tomato flu. It can spread through close contact with infected individuals.
WHO: Monkeypox cases drop 21%, reversing month-long increase August 25, 2022: The number of monkeypox cases reported globally dropped by 21% in the last week, reversing a month-long trend of rising infections and a possible signal the outbreak in Europe may be starting to decline, according to a World Health Organisation report issued Thursday.
PCI to make it mandatory for pharmacy colleges to appoint 60% of faculty in Pharm D course from equivalent discipline Mumbai, August 25, 2022: The Pharmacy Council of India (PCI) is gearing up to make it mandatory for pharmacy colleges to ensure that 60 per cent of total faculty in six-year Pharm. D programme are Pharm. D graduates following the demand of pharmacy associations.
Delhi HC dismisses Sun Pharma’s appeal against Hetero for infringement of its trade mark Letroz New Delhi, September 1, 2022: A division bench of the Delhi High Court has dismissed an appeal filed by Sun Pharmaceutical Laboratories against Hetero Healthcare related to an alleged infringement of its trade mark Letroz, a generic drug for second line treatment of advanced breast cancer.
Young children are at increased risk of tomato flu: Lancet studyAugust 23, 2022: Young children are at increased risk of exposure to tomato flu, and if not controlled and prevented, the transmission might lead to serious consequences by spreading in adults as well, warns a recent study published in The Lancet Respiratory Medicine journal.
National Injections
KSRPA urges govt to cancel licenses of those pharmacists who have not renewed their registration Bengaluru, August 25, 2022: The Karnataka State Registered Pharmacists Association (KSRPA) has urged the state government to cancel the drug licenses of those pharmacists who have not renewed their registration. This follows after the Karnataka High Court upheld the need to adhere to the Drugs and Cosmetics Act and Rules.
Discontent members of TN CDA to form parallel trade bodyChennai, August 26, 2022: Discontent members of the Tamil Nadu Chemists and Druggists Association (TN CDA) are uniting once again under the oldest banner, Chemists and Druggists Association Chennai (C&D Chennai), the first drug traders' outfit formed in the country in 1926, to form a parallel association to work for the welfare of ordinary members in the traders' community.
Kerala govt seeks possibilities for forming registration council for Ayur B Pharm graduates Chennai, August 24, 2022: Exploring ways to establish one registration council for the Ayurveda pharmacy graduates (Ayur B Pharm) on the lines of the state pharmacy council of modern medicines, the government of Kerala has sought suggestions from the Department of Drugs Control Administration under which the Ayurveda drug regulatory wing is functioning.
Maharashtra FDA sets timelines for various regulatory approvals Mumbai, August 30, 2022: The Maharashtra Food and Drugs Administration (FDA) has set timelines for various regulatory approvals with an aim to make approval process transparent and facilitate ease of doing business.
Mysuru to host 25th Annual National Convention of APTI 2022 Bengaluru, August 30, 2022: Mysuru beckons high quality pedagogy as it plays host to the 25th Annual National Convention of Association of Pharmaceutical Teachers of India (APTI). The event will be held from September 2 to 4, 2022 at the JSS Academy of Higher Education and Research (JSS AHER) campus which houses the JSS Pharmacy College ranked among the top 8 pharmacy colleges in the country.
Noida twin towers: People with respiratory issues should avoid area for few days, say doctors August 28, 2022: As the nearly 100-metre-tall Supertech twin towers were razed to the ground on Sunday, doctors said people living nearby, especially those suffering from respiratory diseases, should take extra care and avoid the area for a few days if possible.
Global Injections
First Death in U.S. of a Person WithMonkeypox Confirmed in TexasAugust 31, 2022: Texas officials have reported the first death of a person with monkeypox in the United States, according to a news release from the Texas Department of State Health Services.
FDA Authorizes Updated COVID Boosters to Target Newest VariantsAugust 31, 2022: The FDA on Wednesday granted emergency use authorization to Omicron-specific COVID-19 vaccines made by Pfizer/BioNTech and Moderna.
USDA Scatters Oral Rabies Vaccines for Wildlife in 13 States
August 29, 2022: The U.S. Department of Agriculture is dropping nearly 4 million packets of oral rabies vaccines from heli-copters, planes, and vehicles in 13 states, stretching from Alabama to Maine.
Statin pills rarely cause muscle pain or problems, study finds
August 30, 2022: People on cholesterol-lowering statins can be reassured that it is uncommon for the tablets to cause muscle pain, say the authors of a large study.
South Korea records world's lowest fertility rate again
August 26, 2022: South Korea has again recorded the world's lowest fertility rate with the number sinking to a new low. The rate in the country first dropped lower than one child per woman in 2018.
Brain stimulation boosts memory for a month
August22, 2022: Scientists have discovered they can boost people's memory for a least a month by harmlessly stimulating parts of the brain with electricity.
PSAIIF PILL
New Drugs Bill should ensure obligation from buyers to purchase only certified medical devices: AiMeD
New Delhi, September 1, 2022: The medical devices industry has urged the Centre to ensure obligation on the part of the buyer or users to purchase or use only those medical devices with required licenses and certifications under the New Drugs, Medical Devices and Cosmetics (NDMDC) Bill, 2022, the draft of which has been circulated by the Union Health Ministry for stakeholder’s feedback in July this year.
Pharmexcil urges Centre to make reimbursement for BA/BE studies conducted in labs not accredited by NABL
Mumbai, September 1, 2022: The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has urged the Union Commerce Ministry to make drug manufacturers/ exporters eligible for reimbursement of expense on bioavailability and bioequivalence (BA/BE) studies conducted in laboratories lacking NABL accreditation under Market Access Initiatives (MAI) Scheme.
Frequently Asked Questions
Is There a Best Time of Day to Take Your Blood Pressure Pill?
It doesn't seem to matter what time of day or night you take your blood pressure medication, a new study finds. The results of a randomized trial of more than 21,000 patients with high blood pressure who were fol-lowed for over five years show that protection against heart attack, stroke and vascular death is not affected if the drugs are taken in the morning or evening. Read More>>>
SUBSCRIBER'S SYMPTOM
Health on a platter: Taking the wellness route
August 28, 2022: At a time when many people were experimenting with Ayurvedic decoctions, herbs and spices to ward off the Covid-19 pandemic, chefs RishabhAnand and Simran Singh Thapar of the Leela Palaces, Hotels and Resorts, along with food consultant AnkitaJalori, were working to curate a menu that promotes health along with wellness. The result— Aujasya, a signature wellness programme that focuses on 2 ‘R’s—‘restore’ (food) and ‘renew’ (mindfulness).
Consumer Online Foundation: The first and only organisation certified as per international standard ISO 9001:2015 for Consumer Complaint Redressal Services
First and the only organization in India to be certified on 21st September 2021 as an ISO 9001:2015 on Consumer Complaint Redressal Services. We are proud to share our achievements with our readers and supporters. Thanks for your continued support and guidance for more than 35+ years of service to the consumers in India and abroad.
Blog Addicts
Mrs. Sunaina Gupta, Medical journalist: Right to quality healthcare is right of every citizen, both those residing in urban areas as well rural. Thanks PSAI India for creating the awareness amongst common people like us!
AvinashRaut, Pharma professionalThe PSA-India’s initiated “The Prescription” newsletter provides beneficial information and a very positive endeavour.
Dr. Lopamudra Dixit, Physician:
India continues to be among those countries of the world that have a high burden of diseases. Thanks PSA India for updated news on such crucial matters!
This Newsletter is brought to you by
Patient Safety And Access Initiative of India Foundation
B306, First Floor, C R Park, New Delhi -110019
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources .
PSAIIF may not be held responsible for any article published in The Prescription.
